Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | RA Capital Management, L.P. | 5,199,746 9.990% | 1,689,643 (+48.14%) | Filing History |
| 2023-02-14 2:35 pm Sale | 2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | Perceptive Advisors LLC | 1,800,000 3.600% | -350,641 (-16.30%) | Filing History |
| 2023-02-13 6:02 pm Purchase | 2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BIOTECHNOLOGY VALUE FUND L P | 4,917,774 9.990% | 1,321,017 (+36.73%) | Filing History |
| 2023-02-13 09:25 am Unchanged | 2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE | Kynam Capital Management, LP | 4,420,349 9.200% | 0 (Unchanged) | Filing History |
| 2023-02-10 3:51 pm Purchase | 2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE | Kynam Capital Management, LP | 4,420,349 9.200% | 4,420,349 (New Position) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | RA Capital Management, L.P. | 3,510,103 9.990% | 1,686,583 (+92.49%) | Filing History |
| 2022-02-14 3:46 pm Unchanged | 2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | Perceptive Advisors LLC | 2,150,641 6.200% | 0 (Unchanged) | Filing History |
| 2022-01-13 10:20 am Sale | 2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BANK OF AMERICA CORP BAC | 1,007,258 2.900% | -870,960 (-46.37%) | Filing History |
| 2021-11-15 4:58 pm Purchase | 2021-11-03 | 13G | Concert Pharmaceuticals, Inc. CNCE | BIOTECHNOLOGY VALUE FUND L P | 3,596,757 9.990% | 3,596,757 (New Position) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Concert Pharmaceuticals, Inc. CNCE | BlackRock Inc. BLK | 670,035 2.100% | -1,534,474 (-69.61%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | RA Capital Management, L.P. | 1,823,520 5.900% | 1,823,520 (New Position) | Filing History |
| 2021-02-16 3:30 pm Unchanged | 2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | Perceptive Advisors LLC | 2,150,641 7.000% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:38 pm Sale | 2021-02-16 | 13G | Concert Pharmaceuticals, Inc. CNCE | Dimensional Fund Advisors LP | 1,079,170 3.500% | -129,831 (-10.74%) | Filing History |
| 2021-02-09 4:41 pm Sale | 2005-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | INGALLS & SNYDER LLC | 1,396,003 4.550% | -68,709 (-4.69%) | Filing History |
| 2021-02-08 5:06 pm Purchase | 2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BANK OF AMERICA CORP BAC | 1,878,218 6.100% | 67,012 (+3.70%) | Filing History |
| 2021-02-02 2:56 pm Purchase | 2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BlackRock Inc. BLK | 2,204,509 7.200% | 735,550 (+50.07%) | Filing History |